Proteomic analysis of two types of exosomes in human whole saliva

Y Ogawa, Y Miura, A Harazono… - Biological and …, 2011 - jstage.jst.go.jp
Y Ogawa, Y Miura, A Harazono, M Kanai-Azuma, Y Akimoto, H Kawakami, T Yamaguchi…
Biological and Pharmaceutical Bulletin, 2011jstage.jst.go.jp
MATERIALS AND METHODS Materials Gly-Pro-4-methyl-coumaryl-7-amide (Gly-Pro-MCA)
was from Peptide Institute Inc.(Osaka, Japan). Sephacryl S-500 HR, Immobiline DryStrip gel
and Pharmalyte were purchased from GE Healthcare UK Ltd.(Buckinghamshire, UK). a-
Cyano-4-hydroxycinnamic acid (4-CHCA) was purchased from Shimadzu GLC (Tokyo,
Japan). CXCL11 and CXCL12 were from R&D Systems, Inc.(Minnesota, USA). All other
reagents were of the highest quality available. DPP IV inhibitor ER319711-15 was kindly …
MATERIALS AND METHODS
Materials Gly-Pro-4-methyl-coumaryl-7-amide (Gly-Pro-MCA) was from Peptide Institute Inc.(Osaka, Japan). Sephacryl S-500 HR, Immobiline DryStrip gel and Pharmalyte were purchased from GE Healthcare UK Ltd.(Buckinghamshire, UK). a-Cyano-4-hydroxycinnamic acid (4-CHCA) was purchased from Shimadzu GLC (Tokyo, Japan). CXCL11 and CXCL12 were from R&D Systems, Inc.(Minnesota, USA). All other reagents were of the highest quality available. DPP IV inhibitor ER319711-15 was kindly provided from Eisai Co., Ltd.(Ibaraki, Japan).
jstage.jst.go.jp